TipRanks
Corbus Pharmaceuticals (DE:3371)
FRANKFURT:3371
Germany Market
3371
Corbus Pharmaceuticals
RESEARCH TOOLSreports

Corbus Pharmaceuticals (3371) Stock News & Sentiment

0 Followers
Corbus Pharmaceuticals: Buy Rating Reaffirmed as CRB-913 Phase 1b Data Impress; $38 Price Target Maintained
Premium
Ratings
Corbus Pharmaceuticals: Buy Rating Reaffirmed as CRB-913 Phase 1b Data Impress; $38 Price Target Maintained
20d ago
CRBP
Corbus Reports Positive Phase 1b Results for CRB-913
Premium
Company Announcements
Corbus Reports Positive Phase 1b Results for CRB-913
21d ago
8K
CRBP
Buy Rating Reiterated on Corbus Pharmaceuticals as CRB-701 Data Strengthen Long-Term Outlook; $35 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on Corbus Pharmaceuticals as CRB-701 Data Strengthen Long-Term Outlook; $35 Price Target Maintained
1M ago
CRBP
CRBP’s CRB-701 Phase 3 Trial Sets the Stage for a Key Oncology Catalyst
Premium
Company Announcements
CRBP’s CRB-701 Phase 3 Trial Sets the Stage for a Key Oncology Catalyst
2M ago
CRBP
Corbus Buy Rating Reaffirmed as Advancing Pipeline and Upcoming Catalysts Support Upside with Unchanged $38 Price Target
Premium
Ratings
Corbus Buy Rating Reaffirmed as Advancing Pipeline and Upcoming Catalysts Support Upside with Unchanged $38 Price Target
2M ago
CRBP
Corbus Highlights Wider Loss and Strengthened Liquidity Position
Premium
Company Announcements
Corbus Highlights Wider Loss and Strengthened Liquidity Position
2M ago
8K
CRBP
Corbus Pharmaceuticals Appoints CMO Amid Key Trial Launches
Premium
Company Announcements
Corbus Pharmaceuticals Appoints CMO Amid Key Trial Launches
3M ago
8K
CRBP
More DE:3371 News >

3371 News on the Web

RA Capital Management Acquires 1,914,788 Shares of Corbus Pharmaceuticals (CRBP)
GuruFocus News
Bullish
Analysts’ Top Healthcare Picks: Corbus Pharmaceuticals (CRBP), Definium Therapeutics (DFTX)
TipRanks News
Bullish
Corbus Pharmaceuticals announces topline data from CANYON-1 trial
TipRanks News
Bullish
Corbus Reports Positive Phase 1b Results for CRB-913
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Corbus Pharmaceuticals (CRBP) and Korro Bio (KRRO)
TipRanks News
Bullish
Corbus Pharmaceuticals Appoints CMO Amid Key Trial Launches
TipRanks News
Neutral
Corbus Pharmaceuticals appoints Viana Nicacio as chief medical officer
TipRanks News
Neutral
Corbus Pharmaceuticals price target lowered to $34 from $44 at Mizuho
TipRanks News
Bullish

News Score - Last 7 Days

Positive
DE:3371
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:3371’s Media Buzz Sentiment?
2 articles about DE:3371 were published this week. In an average week, 2.5 articles are published.
    What is DE:3371’s weekly average amount of articles?
    In an average week, 2.5 articles about DE:3371 are published.
      What is DE:3371’s News Sentiment?
      100% of articles about DE:3371 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        BAYRYBayer
        ABTAbbott Laboratories
        INCYIncyte
        SMMTSummit Therapeutics
        CRVOCervoMed
        Showing the stocks with the most bullish news sentiment over the past week